Call for papers for a collection on placebo and nocebo effects in psychiatry - excellent! @sipsplacebo.bsky.social @timnicholson.bsky.social @devinterhune.bsky.social @labasedow.bsky.social @bnpa.bsky.social @sfb-trr-289.bsky.social
That's it for this week.
For next week I'll mainly try to read this handbook: zenodo.org/records/1569...
I'll see how far I get and might post a few more thoughts than usual.
Just read the abstract but I think its always great to highlight the importance of exposure for the therapy of anxiety.
karger.com/pps/article/...
As a very drug-focused addiction researcher I think its always worthwhile to check out the work on behavioral addictions. Alwyas interesting parallels to find there!
www.sciencedirect.com/science/arti...
Fantastic approach to investigating a common problem: abstinence motivation conflicting with a pro-use environment. Cements my opinion that the main problem with drug policy is profit oriented drug distribution (independent of its legal status).
www.sciencedirect.com/science/arti...
Always interesting to get a glimpse into qualitative research. Also adresses a problem that I think might be more common than would be expected when focusing on such a u.s.-centric issue.
psychiatryonline.org/doi/10.1176/...
Gonna break my self-imposed rule and add a second skeet: This took some time to work through, but was very much worth it. Such a pleasure to read a wonderfully written review by a true expert in their field. A real "That's how I want to write science" type of work!
"Like numbers, space and time may be built out of our actions in our niche and through societal agreements and hold no meaning in a world devoid of humans."
www.nature.com/articles/s41...
Another preliminary finding (lots of those in psychedelic research). Imo psychedelics might really be beneficial for palliative care and dealing with chronic illness. (Last psychedelic study for this week, I promise).
www.nature.com/articles/s41...
Like iboga, 5meoDMT seems like a different beast compared to the classical psychedelics. I definitely see potential here, but still very preliminary findings (and again industry sponsored).
journals.sagepub.com/doi/full/10....
A layperson-oriented and short overview regarding psychedelic science. Definitely a good intro text.
portlandpress.com/biochemist/a...
If this was of interest to you also check out this very recent and quite extensive review from @jhpsychedelics.bsky.social
www.bmj.com/content/392/...
A long but important read that imo covers most of the current issues with clinical trials involving psychedelics.
journals.sagepub.com/doi/10.1177/...
Back on my psychedelic research grind. Quite promising results from this non-randomized trial. Im actually slightly optimistic regarding the potential of psychedelics for more neurolologically determined conditions.
www.nature.com/articles/s41...
Part 2 of this week. Papers I have read March 5th - March 8th:
🎉 I just published my second paper! Woo!
In psychotherapy trials we often see that symptoms reduce between screening and start of treatment. A plausible idea about that is that patients self-refer when their fluctuating symptoms are extra bad. We checked! (we tried to check) //
And that's a middle of the week break 🙂. As planned, fewer psychedelic papers. But still have lots on the reading list!
Again, absolutely impressed by the complexity and thouroughness necessary for neuroscientific questions and publications. www.cell.com/neuron/fullt...
A great comment by @theborislab.bsky.social (www.sciencedirect.com/science/arti...) on an already great paper. Really should read both to grasp the importance of the paper. Fascinating work!
www.sciencedirect.com/science/arti...
While a commendable errort, I don't think the authors have reported the influence of alcohol and other substance use, even though they assessed it. My suspicion is these reported associations would also be significant for other drug use.
jamanetwork.com/journals/jam...
Overdose Prevention Centers are indisputably good and necessary. There really is no sensible argument against providing these services. Apparently people are concerned such centers would reduce the value of the neighborhood. Well, they don't.
jamanetwork.com/journals/jam...
Imo very important to do this kind of work to figure out potential ways of reducing the need for psychopharmacological agents. As, nearly, always in pharmacological trials no words on psychotherapy...
jamanetwork.com/journals/jam...
I understand little of the brains electromagnetic properties and even less of the necessary physics. Still, this is the first theory of consciousness that I feel like I can grasp (not sure if thats a good thing).
pmc.ncbi.nlm.nih.gov/articles/PMC...
Neurons are complicated and different parts of the neuron are responsible for different kinds of signals (I guess, I really only understand parts of this work)
www.nature.com/articles/s41...
A short, German, perspective on the need of harm reduction approaches for people affected by psychotic disorders with comorbid crack use disorders.
www.thieme-connect.de/products/ejo...
Beautifully written essay by @philipcball.bsky.social "It seems possible that the very complexity of biology engenders an undue and unhelpful determination to sustain old, simple narratives beyond the point where they are useful [...]"
www.sciencedirect.com/science/arti...
A fascinating look into fly cognition. Always love the cross-species similarities emerging from an evolutionary perspective.
www.cell.com/trends/cogni...
Papers I have read, March 2nd - March 4th:
Fontana thinking his 6000+ experiments may not have been enough to feel confident in his conclusions in the 18th century while we expect our singular experiments and their standalone replications to do wonders some 250 years later... (excerpt from the intro of Jutta Schickore's About Experiment)
🤨